A Phase II, Open-Label, Multi-Center Study to Assess the

Project: Research project

Description

A Phase II, Open-Label, Multi-Center Study to Assess the Pharmacokinetics, Long-Term Safety and Tolerability of Tracolimus
StatusFinished
Effective start/end date8/1/0210/29/09

Funding

  • Astellas Pharma US, Inc.

Fingerprint

Pharmacokinetics
Safety